Business
Acadia Healthcare Announces Fourth Quarter and 2025 Results
Company Provides First Quarter and Full Year 2026 Guidance Debbie Osteen Joins Acadia as Chief Executive Officer FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia
About this update from Acadia Healthcare Company, Inc.
[{"type":"text","content":"\nCompany Provides First Quarter and Full Year 2026 Guidance\n\n\nDebbie Osteen Joins Acadia as Chief Executive Officer\n\n\n FRANKLIN, Tenn.--(BUSINESS WIRE)--\nAcadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025.\n\n\nFourth Quarter 2025 Results\n\n\n\nRevenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company’s previously issued guidance range\n\n\n\nSame facility revenue increased 4.4% compared with the fourth quarter of 2024, including an increase in patient days of 3.1% and an increase in revenue per patient day of 1.3%\n\n\n\nNet loss attributable to Acadia totaled $(13.02) per diluted share, compared with net income of $0.35 per diluted share in the prior-year period driven by a non-cash goodwill impairment charge of $996.2 million\n\n\n\nAdjusted net income attributable to Acadia totaled $6.1 million, or $0.07 per diluted share, compared with $59.2 million, or $0.64 per diluted share in the prior-year period\n\n\n\nAdjusted EBITDA was $99.8 million, compared with $153.1 million in the prior-year period and at the upper end of the Company’s implied fourth-quarter guidance range. Fourth quarter 2025 Adjusted EBITDA includes a $52.7 million adjustment to professional and general liability (“PLGL”) reserves, as previously disclosed on December 2, 2025\n\n\n\nAdded 181 newly licensed beds during the fourth quarter, including 37 beds to existing facilities and 144 beds from new facilities opened in the fourth quarter\n\n\n\nFull Year 2025 Results\n\n\n\nRevenue totaled $3,312.8 million, a 5.0% increase compared with the prior year\n\n\n\nNet loss attributable to Acadia totaled $(12.16) per diluted share, compared with net income of $2.78 per diluted share during the prior year\n\n\n\nAdjusted net income attributable to Acadia totaled $182.7 million, or $2.00 per diluted share, compared with $304.1 million, or $3.30 per diluted share during the prior-year\n\n\n\nAdjusted EBITDA was $608.9 million, compared with $709.0 million in the prior year\n\n\n\nAdded 1,089 licensed beds during the year, including 311 to existing facilities and 778 beds from new facilities opened during the year\n\n\n\nFull Year 2026 Financial Guidance\n\n\n\n...